EODData

MEMBERSHIP REGISTER LOG IN

FRA, 5GH: GUARDANT HEALTH CL. A

26 May 2026
LAST:

102.6

CHANGE:
 0.42		OPEN:
102.6		HIGH:
102.6		ASK:
0.0		VOLUME:
0
CHG(%):
0.41		PREV:
103.0		LOW:
102.6		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 May 26102.6102.6102.6102.60
25 May 26103.0103.0103.0103.00
22 May 26101.7101.7101.6101.60
21 May 2698.498.498.198.10
20 May 2684.484.484.484.40
19 May 2681.382.281.382.1358
18 May 2680.880.880.880.80
15 May 2683.783.783.783.70
14 May 2683.783.783.783.70
13 May 2685.185.185.185.10

PROFILE

Name:GUARDANT HEALTH CL. A
About:Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Sector:Healthcare
Address:3100 Hanover Street, Palo Alto, CA, United States, 94304
Website:https://guardanthealth.com
ISIN:US40131M1099
LEI:254900M8C3E5VC8BR186

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-24.05 
Forward P/E:-25.41 
PEG Ratio:-25.41 
Price to Sales:12.58 
Price to Book:-33.68 
Profit Margin:-0.44 
Operating Margin:-0.37 
Return on Assets:-0.20 
Return on Equity:3.12 
Revenue:765.87M 
Shares:124.71M 
Market Cap:12.79B 

TECHNICAL INDICATORS

MA5:97.924.7%
MA10:90.5113.3%
MA20:83.4123.0%
MA50:78.2431.1%
MA100:83.4622.9%
MA200:74.0238.6%
STO9:98.11 
STO14:98.44 
RSI14:83.15 
WPR14:-1.56 
MTM14:26.55
ROC14:0.35 
ATR:2.73 
Week High:102.980.4%
Week Low:81.3126.1%
Month High:102.980.4%
Month Low:70.9738.6%
Year High:102.980.4%
Year Low:33.40207.0%
Volatility:41.54